ClinicalTrials.Veeva

Menu

Effect of Whole Grain Diet on Insulin Sensitivity, Advanced Glycation End Products and Inflammatory Markers in Pre-diabetes

Mount Sinai Health System logo

Mount Sinai Health System

Status

Completed

Conditions

Prediabetes
Diabetes

Treatments

Other: Whole grain rice
Other: Refined grain rice

Study type

Interventional

Funder types

Other

Identifiers

NCT01248286
10-0924 0001 01 ME (Other Identifier)
GCO 10-0924

Details and patient eligibility

About

Food products derived from cereal grains constitute a major part of the daily diet of many Americans . For example, a typical Chinese American eats rice about 9.5 times a week on an average. However, most of these foods are derived from refined grain. During the refining process grains are stripped of their bran and germ which results in depletion of several biologically active constituents including fiber, anti-oxidants, phytoestrogens and minerals. From observational studies there is evidence for a protective effect of whole-grain foods with regard to the development of type 2 diabetes. More recently, higher intake of whole grains was also associated with decreases in insulin resistance - a risk factor related to the development of type 2 diabetes.

In this randomized study the investigators plan to replicate this beneficial effect of improving insulin sensitivity in patients with pre-diabetes and go a step further by exploring the potential mechanisms by which this benefit may occur. The investigators will assess the effect of consuming a whole-grain-rich diet on levels of advanced glycation endproducts (AGE), RAGE (receptor for AGE) and markers of inflammation and oxidative stress - all of which have been shown to play an important role in the pathogenesis of diabetes mellitus. The investigators will also look for correlations between the levels of these markers with insulin sensitivity to identify potential mechanisms of pathogenesis.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥ 18 years to unlimited, both genders.
  2. At least one meal per day included rice in the seven days prior to enrolment.
  3. No current diagnosis of Diabetes Mellitus (DM).
  4. Fasting blood glucose value between 100 to 125 mg/dl and/or Hemoglobin A1c levels between 5.7%-6.4%.
  5. ≥ 2 visits with primary care physician to establish compliance

Exclusion criteria

  1. Special diets (e.g. vegetarian)
  2. Use of medications that would affect blood sugar levels (e.g. steroids)
  3. Allergy to any type of grain
  4. Body weight fluctuation over the past 180 days of ≥ 10%
  5. Planning to significantly change level of physical activity during the time of study.
  6. Planning to move out of town or take a vacation for ≥ 14 days during the time of the study
  7. Current smoker
  8. Consumption of greater than 2 alcoholic drinks per day
  9. History of malignancy and overt cardiovascular disease (apart from hypertension).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Whole grain rice
Experimental group
Treatment:
Other: Whole grain rice
Refined grain rice
Active Comparator group
Treatment:
Other: Refined grain rice

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems